Amir Klein1, David J Tate2, Vanoo Jayasekeran1, Luke Hourigan3, Rajvinder Singh4, Gregor Brown5, Farzan F Bahin2, Nicholas Burgess2, Stephen J Williams1, Eric Lee1, Mayenaaz Sidhu1, Karen Byth6, Michael J Bourke7. 1. Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, NSW, Australia. 2. Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, NSW, Australia; Westmead Clinical School, University of Sydney, NSW, Australia. 3. Department of Gastroenterology and Hepatology Princess Alexsandra Hospital, Brisbane, QLD, Australia; Gallipoli Medical Research Institute, School of Medicine, The University of Queensland, Greenslopes Private Hospital, Brisbane, QLD, Australia. 4. Department of Gastroenterology and Hepatology Lyell McEwin Hospital, Adelaide, SA, Australia. 5. Department of Gastroenterology and Hepatology Alfred Hospital, Melbourne, VIC, Australia. 6. Westmead Clinical School, University of Sydney, NSW, Australia. 7. Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, NSW, Australia; Westmead Clinical School, University of Sydney, NSW, Australia. Electronic address: michael@citywestgastro.com.au.
Abstract
BACKGROUND & AIMS:Colorectal cancer (CRC) can be prevented by colonoscopy and polypectomy. Endoscopic mucosal resection (EMR) is performed to remove large laterally spreading colonic lesions that have a high risk of progression to CRC. Endoscopically invisible micro-adenomas at the margins of the EMR site might contribute to adenoma recurrence, which occurs in 15% to 30% of patients who undergo surveillance. We aimed to determine the efficacy of adjuvant thermal ablation of the EMR mucosal defect margin in reducing polyp recurrence. METHODS: We performed a prospective study of 390 patients with large laterally spreading colonic lesions (≥ 20 mm, n = 416) referred for EMR at 4 tertiary centers in Australia. After complete lesion excision by EMR, lesions were randomly assigned to thermal ablation of the post-EMR mucosal defect margin (n = 210) or no additional treatment (controls, n = 206). We performed surveillance colonoscopies with standardized photo documentation and biopsies of the scar after 5 to 6 months. Patient, procedure, and lesion characteristics were similar between the groups. The primary endpoint was detection of lesion recurrence at first surveillance colonoscopy. RESULTS: A significantly lower proportion of patients who received thermal ablation of the post-EMR mucosal defect margin had evidence of recurrence at first surveillance colonoscopy (10/192, 5.2%) than controls (37/176, 21.0%) (P < .001). The relative risk of recurrence in the thermal ablation group was 0.25 compared with the control group (95% confidence interval 0.13-0.48). Rates of adverse events were similar between the groups. CONCLUSIONS: In a multicenter randomized trial, thermal ablation of the post-EMR mucosal defect margin significantly reduced polyp recurrence at first surveillance colonoscopy, compared with no additional treatment. Routine implementation of this simple and safe technique could increase the utility of EMR, decrease surveillance burdens, and reduce morbidity and mortality from CRC. ClinicalTrials.gov no: NCT01789749.
RCT Entities:
BACKGROUND & AIMS:Colorectal cancer (CRC) can be prevented by colonoscopy and polypectomy. Endoscopic mucosal resection (EMR) is performed to remove large laterally spreading colonic lesions that have a high risk of progression to CRC. Endoscopically invisible micro-adenomas at the margins of the EMR site might contribute to adenoma recurrence, which occurs in 15% to 30% of patients who undergo surveillance. We aimed to determine the efficacy of adjuvant thermal ablation of the EMR mucosal defect margin in reducing polyp recurrence. METHODS: We performed a prospective study of 390 patients with large laterally spreading colonic lesions (≥ 20 mm, n = 416) referred for EMR at 4 tertiary centers in Australia. After complete lesion excision by EMR, lesions were randomly assigned to thermal ablation of the post-EMR mucosal defect margin (n = 210) or no additional treatment (controls, n = 206). We performed surveillance colonoscopies with standardized photo documentation and biopsies of the scar after 5 to 6 months. Patient, procedure, and lesion characteristics were similar between the groups. The primary endpoint was detection of lesion recurrence at first surveillance colonoscopy. RESULTS: A significantly lower proportion of patients who received thermal ablation of the post-EMR mucosal defect margin had evidence of recurrence at first surveillance colonoscopy (10/192, 5.2%) than controls (37/176, 21.0%) (P < .001). The relative risk of recurrence in the thermal ablation group was 0.25 compared with the control group (95% confidence interval 0.13-0.48). Rates of adverse events were similar between the groups. CONCLUSIONS: In a multicenter randomized trial, thermal ablation of the post-EMR mucosal defect margin significantly reduced polyp recurrence at first surveillance colonoscopy, compared with no additional treatment. Routine implementation of this simple and safe technique could increase the utility of EMR, decrease surveillance burdens, and reduce morbidity and mortality from CRC. ClinicalTrials.gov no: NCT01789749.
Authors: Pujan Kandel; Monia E Werlang; Issac R Ahn; Timothy A Woodward; Massimo Raimondo; Ernest P Bouras; Michael B Wallace; Victoria Gómez Journal: Dig Dis Sci Date: 2019-05-16 Impact factor: 3.199
Authors: Alexey M Osintsev; Ilya L Vasilchenko; Dario B Rodrigues; Paul R Stauffer; Vladimir I Braginsky; Vitaliy V Rynk; Egor S Gromov; Alexander Yu Prosekov; Andrey D Kaprin; Andrey A Kostin Journal: IEEE Trans Magn Date: 2021-07-16 Impact factor: 1.848
Authors: Pujan Kandel; Murtaza Hussain; Deepesh Yadav; Santosh K Dhungana; Bhaumik Brahmbhatt; Massimo Raimondo; Frank J Lukens; Ghassan Bachuwa; Michael B Wallace Journal: Endosc Int Open Date: 2022-10-17
Authors: Tiing Leong Ang; Jit Fong Lim; Tju Siang Chua; Kok Yang Tan; James Weiquan Li; Chern Hao Chong; Kok Ann Gwee; Vikneswaran S/O Namasivayam; Charles Kien Fong Vu; Christopher Jen Lock Khor; Lai Mun Wang; Khay Guan Yeoh Journal: Singapore Med J Date: 2020-07-16 Impact factor: 3.331
Authors: Gottumukkala S Raju; Phillip Lum; Hamzah Abu-Sbeih; William A Ross; Selvi Thirumurthi; Ethan Miller; Patrick Lynch; Jeffrey Lee; Manoop S Bhutani; Mehnaz Shafi; Brian Weston; Asif Rashid; Yinghong Wang; George J Chang; Richard Carlson; Katherine Hagan; Marta Davila; John Stroehlein Journal: Endosc Int Open Date: 2020-01-22